sulpiride has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 13 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Evaluation revealed levosulpiride, a dopamine receptor blocker commonly used for dyspepsia, to be the culprit." | 3.91 | An Unusual Cause of Camptocormia. ( Kumar, R; Lal, V; Mehta, S, 2019) |
| " Adverse effects include acute dyskinesia or Parkinsonism, which may occur after many months of treatment." | 2.43 | The safety of veralipride. ( De Leo, V; Delia, A; Faldini, E; Morgante, G; Musacchio, MC; Petraglia, F, 2006) |
| "Chronic pain is a common and undertreated nonmotor symptom in Parkinson's disease (PD)." | 1.62 | D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice. ( Luan, YW; Tang, DL; Xiao, C; Zhou, CY, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, DL | 1 |
| Luan, YW | 1 |
| Zhou, CY | 1 |
| Xiao, C | 1 |
| Gómez-Paz, A | 1 |
| Drucker-Colín, R | 1 |
| Milán-Aldaco, D | 1 |
| Palomero-Rivero, M | 1 |
| Ambriz-Tututi, M | 1 |
| Mehta, S | 1 |
| Kumar, R | 1 |
| Lal, V | 1 |
| Pendolino, V | 1 |
| Bagetta, V | 1 |
| Ghiglieri, V | 1 |
| Sgobio, C | 1 |
| Morelli, E | 1 |
| Poggini, S | 1 |
| Branchi, I | 1 |
| Latagliata, EC | 1 |
| Pascucci, T | 1 |
| Puglisi-Allegra, S | 1 |
| Calabresi, P | 1 |
| Picconi, B | 1 |
| Ma, HI | 1 |
| Kim, JH | 1 |
| Chu, MK | 1 |
| Oh, MS | 1 |
| Yu, KH | 1 |
| Kim, J | 1 |
| Hahm, W | 1 |
| Kim, YJ | 1 |
| Lee, BC | 1 |
| Viaro, R | 1 |
| Marti, M | 1 |
| Morari, M | 1 |
| Jones, CA | 1 |
| Johnston, LC | 1 |
| Jackson, MJ | 1 |
| Smith, LA | 1 |
| van Scharrenburg, G | 1 |
| Rose, S | 1 |
| Jenner, PG | 1 |
| McCreary, AC | 1 |
| Martí Massó, JF | 1 |
| Ruiz-Martínez, J | 1 |
| Bergareche, A | 1 |
| López de Munain, A | 1 |
| Ohye, C | 1 |
| Shibazaki, T | 1 |
| Milusheva, E | 1 |
| Baranyi, M | 1 |
| Kittel, A | 1 |
| Sperlágh, B | 1 |
| Vizi, ES | 1 |
| De Leo, V | 1 |
| Morgante, G | 1 |
| Musacchio, MC | 1 |
| Faldini, E | 1 |
| Delia, A | 1 |
| Petraglia, F | 1 |
| Mehta, MA | 1 |
| Sahakian, BJ | 1 |
| McKenna, PJ | 1 |
| Robbins, TW | 1 |
| Galvan, A | 1 |
| Floran, B | 1 |
| Erlij, D | 1 |
| Aceves, J | 1 |
1 review available for sulpiride and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
The safety of veralipride.
Topics: Adult; Aged; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Estrogens; Female; Half-Life; | 2006 |
1 trial available for sulpiride and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
Topics: Adult; Affect; Antipsychotic Agents; Association Learning; Attention; Cognition Disorders; Cross-Ove | 1999 |
11 other studies available for sulpiride and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice.
Topics: Action Potentials; Animals; Chronic Pain; Dopamine Agonists; Dopamine Antagonists; Indoles; Male; Mi | 2021 |
Intrastriatal Chromospheres' Transplant Reduces Nociception in Hemiparkinsonian Rats.
Topics: Animals; Cells, Cultured; Male; Microinjections; Naltrexone; Nociception; Oxidopamine; Pain Measurem | 2018 |
An Unusual Cause of Camptocormia.
Topics: Aged; Brain; Diabetes Complications; Diagnosis, Differential; Dopamine Antagonists; Dyspepsia; Femal | 2019 |
l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.
Topics: Animals; Antiparkinson Agents; Benzazepines; Dentate Gyrus; Disease Models, Animal; Dopamine; Dopami | 2014 |
Diabetes mellitus and drug-induced Parkinsonism: a case-control study.
Topics: Age of Onset; Aged; Contraindications; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Sus | 2009 |
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Do | 2010 |
An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.
Topics: Animals; Apomorphine; Benzoxazoles; Callithrix; Dopamine Agonists; Female; Male; Mice; Motor Activit | 2010 |
[Parkinsonism induced by sulpiride and veralipride: two different stories].
Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Hum | 2011 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio | 2001 |
Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment.
Topics: Acetylcholine; Animals; Corpus Striatum; Dopamine; Hydrogen Peroxide; Male; Oxidative Stress; Parkin | 2005 |
Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat.
Topics: Animals; Apomorphine; Benzazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; gamma-Aminobu | 2001 |